Skip to main content

Herzerkrankungen in der Schwangerschaft

This is a preview of subscription content, access via your institution.

Literatur

  1. 1.

    Autore C, Conte MR, Piccininno M, Bernabò P, Bonfiglio G, Bruzzi P and Spirito P (2002). Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 40: 1864–1869

    PubMed  Article  Google Scholar 

  2. 2.

    Avila WS, Rossi EG, Ramires JA, Grinberg M, Bortolotto MR, Zugaib M and da Luz PL (2003). Pregnancy in patients with heart disease: experience with 1000 cases. Clin Cardiol 26: 135–142

    PubMed  Article  Google Scholar 

  3. 3.

    Bac DJ, Lotgering FK, Verkaaik AP and Deckers JW (1995). Spontaneous coronary artery dissection during pregnancy and post partum. Eur Heart J 16: 136–138

    PubMed  CAS  Google Scholar 

  4. 4.

    Baddour LM, Wilson WR and Bayer AS et al (2005). Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111: e394–434

    PubMed  Article  Google Scholar 

  5. 5.

    Banning AP, Pearson JF and Hall RJ (1993). Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 70: 544–545

    PubMed  CAS  Article  Google Scholar 

  6. 6.

    Barbour LA, Kick SD and Steiner JF et al (1994). A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 170: 862–869

    PubMed  CAS  Google Scholar 

  7. 7.

    Barbour LA, Oja JL and Schultz LK (2004). A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol 191: 1024–1029

    PubMed  CAS  Article  Google Scholar 

  8. 8.

    Barton JR, O’Brien JM, Bergauer NK, Jacques DL and Sibai BM (2001). Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184: 979–983

    PubMed  CAS  Article  Google Scholar 

  9. 9.

    Bates SM, Greer IA, Hirsh J and Ginsberg JS (2004). Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(Suppl 3): 627–644

    Article  Google Scholar 

  10. 10.

    Beauchesne LM, Warnes CA, Connolly HM, Ammash NM, Tajik AJ and Danielson GK (2002). Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. J Am Coll Cardiol 40: 285–290

    PubMed  Article  Google Scholar 

  11. 11.

    Benlolo S, Lefoll C, Katchatouryan V, Payen D and Mebazaa A (2004). Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 98: 822–824

    PubMed  Article  Google Scholar 

  12. 12.

    Bertsche T, Haas M, Oberwittler H, Haefeli WE and Walter-Sack I (2006). Drugs during pregnancy and breast-feeding: new risk categories – antibiotics as a model. Dtsch Med Wochenschr 131: 1016–1022

    PubMed  CAS  Article  Google Scholar 

  13. 13.

    Bonnar J (1994). Haemostasis and coagulation disorders in pregnancy. In: Bloom, AL and Thomas, DP (eds) Haemostasis and Thrombosis. Churchill Livingstone, London, pp 570–583.

    Google Scholar 

  14. 14.

    Bonow RO, Carabello B and de Leon AC Jr et al (1998). Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 98: 1949–1984

    CAS  PubMed  Google Scholar 

  15. 15.

    Bonow RO, Carabello BA and Chatterjee K et al (2006). ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guide-lines for the Management of Patients with Valvular Heart Disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1–148

    PubMed  Article  Google Scholar 

  16. 16.

    Brancazio LR, Roperti KA, Stierer R and Laifer SA (1995). Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol 173: 1240–1245

    PubMed  CAS  Article  Google Scholar 

  17. 17.

    Brizzi P, Tonolo G, Esposito F, Puddu L, Dessole S, Maioli M and Milia S (1999). Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol 181: 430–434

    PubMed  CAS  Article  Google Scholar 

  18. 18.

    Brown MA, Hague WM and Higgins J et al (2000). The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 40: 139–155

    PubMed  CAS  Article  Google Scholar 

  19. 19.

    Brown MA, Lindheimer MD, de Swiet M, Van Assche A and Moutquin JM (2001). The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: IX–XIV

    PubMed  CAS  Article  Google Scholar 

  20. 20.

    Burn J, Brennan P and Little J et al (1998). Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351(9099): 311–316

    PubMed  CAS  Article  Google Scholar 

  21. 21.

    Butchart EG, Gohlke-Bärwolf C and Antunes MJ et al (2005). Recommendations for the management of patients after heart valve surgery. Eur Heart J 26: 2463–2471

    PubMed  Article  Google Scholar 

  22. 22.

    Butchart EG, Gohlke-Bärwolf K and Antunes MJ et al (2006). Heart valve disease. In: Butchart, E, Gohlke-Bärwolf, C, Antunes, M, and Hall, RJC (eds) Heart Valve Disease – A Guide to Patient Management after Surgery, 1st edn. Informa Healthcare, London, pp 148–158

    Google Scholar 

  23. 23.

    Calvin S (1998). Use of Vasodil in pregnancy. In: Elkayam, U and Gleicher, N (eds) Cardiac problems in pregnancy, 3rd edn. pp 39–398. Wiley, New York

    Google Scholar 

  24. 24.

    Canobbio MM, Mair DD, van der Velde M and Koos BJ (1996). Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 28: 763–767

    PubMed  CAS  Google Scholar 

  25. 25.

    Caritis S, Sibai B and Hauth J et al (1998). Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 338: 701–705

    PubMed  CAS  Article  Google Scholar 

  26. 26.

    Castelli WP (1999). Cardiovascular disease: pathogenesis, epidemiology and risk among users of oral contraceptives who smoke. Am J Obstet Gynecol 180(6 Pt 2): S349–356

    PubMed  CAS  Article  Google Scholar 

  27. 27.

    Chan WS, Anand S and Ginsberg JS (2000). Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160: 191–196

    PubMed  CAS  Article  Google Scholar 

  28. 28.

    Clarkson PM, Wilson NJ, Neutze JM, North RA, Calder AL and Barratt-Boyes BG (1994). Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 24: 190–193

    PubMed  CAS  Article  Google Scholar 

  29. 29.

    Coletti PM (1998). Cardiovascular imaging in the pregnant patient. In: Elkayam, U and Gleicher, N (eds) Cardiac problems in pregnancy. Wiley-Liss, New York

    Google Scholar 

  30. 30.

    Collins R, Yusuf S and Peto R (1985). Overview of randomised trials of diuretics in pregnancy. BMJ 290: 17–23

    PubMed  CAS  Google Scholar 

  31. 31.

    Connolly HM, Grogan M and Warnes CA (1999). Pregnancy among women with congenitally corrected transposition of great arteries. J Am Coll Cardiol 33: 1692–1695

    PubMed  CAS  Article  Google Scholar 

  32. 32.

    Cooper WO, Hernandez-Diaz S and Arbogast PG et al (2006). Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354: 2443–2451

    PubMed  CAS  Article  Google Scholar 

  33. 33.

    Cox JL and Gardner MJ (1993). Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 36: 137–178

    PubMed  CAS  Article  Google Scholar 

  34. 34.

    Cox SM and Leveno KJ (1989). Pregnancy complicated by bacterial endocarditis. Clin Obstet Gynecol 32: 48–53

    PubMed  CAS  Article  Google Scholar 

  35. 35.

    Cunningham FG and Lindheimer MD (1992). Hypertension in pregnancy. N Engl J Med 326: 927–932

    PubMed  CAS  Google Scholar 

  36. 36.

    Daniel WG, Baumgartner H and Gohlke-Bärwolf C et al (2006). Leitlinien Klappenvitien im Erwachsenenalter. Clin Res Cardiol 95: 620–641

    PubMed  CAS  Article  Google Scholar 

  37. 37.

    de Beus E, van Mook WN, Ramsay G, Stappers JL and van der Putten HW (2003). Peripartum cardiomyopathy: a condition intensivists should be aware of. Intensive Care Med 29: 167–174

    PubMed  Google Scholar 

  38. 38.

    Deanfield J, Thaulow E and Warnes C et al (2003). Management of grown up congenital heart disease. Eur Heart J 24: 1035–1084

    PubMed  Article  Google Scholar 

  39. 39.

    Demakis JG and Rahimtoola SH (1971). Peripartum cardiomyopathy. Circulation 44: 964–968

    PubMed  CAS  Google Scholar 

  40. 40.

    Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM and Cheah G (2000). A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 160: 181–188

    PubMed  CAS  Article  Google Scholar 

  41. 41.

    Dore A and Somerville J (1997). Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J 18: 1659–1662

    PubMed  CAS  Google Scholar 

  42. 42.

    Drenthen W, Pieper PG and Ploeg M et al (2005). Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 26: 2588–2595

    PubMed  Article  Google Scholar 

  43. 43.

    Drenthen W, Pieper PG and van der Tuuk K et al (2005). Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J 26: 2581–2587

    PubMed  Article  Google Scholar 

  44. 44.

    Edison RJ and Muenke M (2004). Central nervous system and limb anomalies in case reports of first-trimester statin exposure. N Engl J Med 350: 1579–1582

    PubMed  CAS  Article  Google Scholar 

  45. 45.

    Elkayam U (1998). Cardiac problems in pregnancy. In: Elkayam, U and Gleicher, N (eds) Cardiac problems in pregnancy, 3rd edn. Wiley-Liss, New York

    Google Scholar 

  46. 46.

    Elkayam U and Bitar F (2005). Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol 46: 223–230

    PubMed  Article  Google Scholar 

  47. 47.

    Elkayam U and Bitar F (2005). Valvular heart disease and pregnancy part II: prosthetic valves. J Am Coll Cardiol 46: 403–410

    PubMed  Article  Google Scholar 

  48. 48.

    Elkayam U and Goodwin TM (1995). Adenosine therapy for supraventricular tachycardia during pregnancy. Am J Cardiol 75: 521–523

    PubMed  CAS  Article  Google Scholar 

  49. 49.

    Elkayam U, Ostrzega E, Shotan A and Mehra A (1995). Cardiovascular problems in pregnant women with the Marfan syndrome. Ann Intern Med 123: 117–122

    PubMed  CAS  Google Scholar 

  50. 50.

    Elkayam U, Tummala PP and Rao K et al (2001). Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344: 1567–1571

    PubMed  CAS  Article  Google Scholar 

  51. 51.

    Elkayam U, Singh H, Irani A and Akhter MW (2004). Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 9: 107–115

    PubMed  CAS  Article  Google Scholar 

  52. 52.

    Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A and Shotan A (2005). Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111: 2050–2055

    PubMed  Article  Google Scholar 

  53. 53.

    Ensom MH and Stephenson MD (1999). Low-molecular-weight heparins in pregnancy. Pharmacotherapy 19: 1013–1025

    PubMed  CAS  Article  Google Scholar 

  54. 54.

    Felker GM, Jaeger CJ and Klodas E et al (2000). Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140: 785–791

    PubMed  CAS  Article  Google Scholar 

  55. 55.

    Ferrero S, Colombo BM and Ragni N (2004). Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 269: 244–253

    PubMed  Article  Google Scholar 

  56. 56.

    Frazier OH and Myers TJ (1999). Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 68: 734–741

    PubMed  CAS  Article  Google Scholar 

  57. 57.

    Frishman WH, Schlocker SJ, Awad K and Tejani N (2005). Pathophysiology and medical management of systemic hypertension in pregnancy. Cardiol Rev 13: 274–284

    PubMed  Article  Google Scholar 

  58. 58.

    Fuster V, Ryden LE and Cannom DS et al (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257–354

    PubMed  Article  Google Scholar 

  59. 59.

    Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS and Petersen P (2004). Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110: 2287–2292

    PubMed  CAS  Article  Google Scholar 

  60. 60.

    Ginsberg JS and Hirsh J (1998). Use of antithrombotic agents during pregnancy. Chest 114(Suppl 5): 524–530

    Article  Google Scholar 

  61. 61.

    Ginsberg JS, Hirsh J, Turner DC, Levine MN and Burrows R (1989). Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 61: 197–203

    PubMed  CAS  Google Scholar 

  62. 62.

    Girndt J (2003). Hochdruck und hypertensiver Notfall in der Schwangerschaft. Herz 28: 185–195

    PubMed  Article  Google Scholar 

  63. 63.

    Gohlke-Bärwolf C (2001). Anticoagulation in pregnancy and post partum in heart valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism. Z Kardiol 90(Suppl 4): 49–56

    PubMed  Google Scholar 

  64. 64.

    Gohlke-Bärwolf CE, Eichstädt H (2004) Herzerkrankungen und Schwangerschaft. In: Roskamm N, Neumann FJ, Kalusche D, Bestehorn HP (Hrsg) Herzkrankheiten, 5. Aufl. Springer, Berlin

  65. 65.

    Gohlke-Bärwolf C, Acar J and Oakley C et al (1995). Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology. Z Kardiol 84: 1018–1032

    Google Scholar 

  66. 66.

    Gohlke-Bärwolf C, Acar J and Oakley C et al (1995). Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 16: 1320–1330

    Google Scholar 

  67. 67.

    Gowda RM, Khan IA, Mehta NJ, Vasavada BC and Sacchi TJ (2003). Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 88: 129–133

    PubMed  Article  Google Scholar 

  68. 68.

    Gruppo di Studio Ipertensione in Gravidanza (1998). Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 105: 718–722

    Google Scholar 

  69. 69.

    Guédès A, Mercier LA, Leduc L, Bérubé L, Marcotte F and Dore A (2004). Impact of pregnancy on the systemic right ventricle after a Mustard operation for transposition of the great arteries. J Am Coll Cardiol 44: 433–437

    PubMed  Article  Google Scholar 

  70. 70.

    Hall JG, Pauli RM and Wilson KM (1980). Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68: 122–140

    PubMed  CAS  Article  Google Scholar 

  71. 71.

    Hall DR, Olivier J, Rossouw GJ, Grové D and Doubell AF (2001). Pregnancy outcome in women with prosthetic heart valves. J Obstet Gynaecol 21: 149–153

    PubMed  CAS  Article  Google Scholar 

  72. 72.

    Hameed A, Karaalp IS and Tummala PP et al (2001). The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 37: 893–899

    PubMed  CAS  Article  Google Scholar 

  73. 73.

    Hanania G (2001). Management of anticoagulants during pregnancy. Heart 86: 125–126

    PubMed  CAS  Article  Google Scholar 

  74. 74.

    Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millaire A and Acar J (1994). Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 15: 1651–1658

    PubMed  CAS  Google Scholar 

  75. 75.

    Hanania G, Thomas D, Michel PL, Garbarz E, Age C, Millaire A and Acar J (1994). Pregnancy in patients with heart valve prosthesis. A French retrospective cooperative study (155 cases). Arch Mal Coeur Vaiss 87: 429–437

    PubMed  CAS  Google Scholar 

  76. 76.

    Hennekens CH (1998). Risk factors for coronary heart disease in women. Cardiol Clin 16: 1–8

    PubMed  CAS  Article  Google Scholar 

  77. 77.

    Hetzer R, Müller JH, Weng Y, Meyer R and Dandel M (2001). Bridging-to-recovery. Ann Thorac Surg 71(Suppl 3): 109–113; discussion 114–115

    Article  Google Scholar 

  78. 78.

    Hilfiker-Kleiner D, Kaminski K and Podewski E et al (2007). A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128: 589–600

    PubMed  CAS  Article  Google Scholar 

  79. 79.

    Högstedt S, Lindeberg S, Axelsson O, Lindmark G, Rane A, Sandström B and Lindberg BS (1985). A prospective controlled trial of metoprolol-hydralazine treatment of hypertension during pregnancy. Acta Obstet Gynecol Scand 64: 505–510

    PubMed  Article  Google Scholar 

  80. 80.

    Holder SE (1997). Genetic counseling. In: Oakley, C (eds) Heart disease in pregnancy. BMJ Publishing, London, pp 401–411

    Google Scholar 

  81. 81.

    Horstkotte D, Follath F and Gutschik E et al (2004). Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25: 267–276

    PubMed  Article  Google Scholar 

  82. 82.

    Iung B and Vahanian A (2002). The long-term outcome of balloon valvuloplasty for mitral stenosis. Curr Cardiol Rep 4: 118–124

    PubMed  Article  Google Scholar 

  83. 83.

    Iung B, Cormier B and Elias J et al (1994). Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy. Am J Cardiol 73: 398–400

    PubMed  CAS  Article  Google Scholar 

  84. 84.

    James PR and Nelson-Piercy C (2004). Management of hypertension before, during and after pregnancy. Heart 90: 1499–1504

    PubMed  Article  Google Scholar 

  85. 85.

    Jamieson WR, Miller DC, Akins CW, Munro AI, Glower DD, Moore KA and Henderson C (1995). Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 60(Suppl 2): 282–286, discussion 287

    Google Scholar 

  86. 86.

    Januzzi JL, Isselbacher EM and Fattori R et al (2004). Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 43: 665–669

    PubMed  Article  Google Scholar 

  87. 87.

    Joglar JA and Page RL (1999). Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 20: 85–94

    PubMed  CAS  Article  Google Scholar 

  88. 88.

    Kaemmerer H and Breithardt G (2006). Empfehlungen zur Qualitätsverbesserung der interdisziplinären Versorgung von Erwachsenen mit angeborenen Herzfehlern (EMAH). Clin Res Cardiol 95(Suppl 4): 76–84

    PubMed  Article  Google Scholar 

  89. 89.

    Kaemmerer H and Hess J (2005). Adult patients with congenital heart abnormalities: present and future. Dtsch Med Wochenschr 130: 97–101

    PubMed  CAS  Article  Google Scholar 

  90. 90.

    Kaemmerer H, Bauer U and Stein JI et al (2003). Pregnancy in congenital cardiac disease: an increasing challenge for cardiologists and obstetricians – a prospective multicenter study. Z Kardiol 92: 16–23

    PubMed  CAS  Article  Google Scholar 

  91. 91.

    Katz NM, Collea JV, Moront MG, MacKenzie RD and Wallace RB (1984). Aortic dissection during pregnancy: treatment by emergency cesarean section immediately followed by operative repair of the aortic dissection. Am J Cardiol 54: 699–701

    PubMed  CAS  Article  Google Scholar 

  92. 92.

    Keogh A, Macdonald P, Spratt P, Marshman D, Larbalestier R and Kaan A (1994). Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant 13: 202–207

    PubMed  CAS  Google Scholar 

  93. 93.

    Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE and Landzberg MJ (2006). Pregnancy outcomes in women with congenital heart disease. Circulation 113: 517–524

    PubMed  Article  Google Scholar 

  94. 94.

    Klein HH and Pich S (2003). Cardiovascular changes during pregnancy. Herz 28: 173–174

    PubMed  Article  Google Scholar 

  95. 95.

    Klieverik LM, Takkenberg JJ, Bekkers JA, Roos-Hesselink JW, Witsenburg M and Bogers AJ (2007). The Ross operation: a Trojan horse. Eur Heart J 28: 1993–2000

    PubMed  Article  Google Scholar 

  96. 96.

    Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M and Lang RM (1997). Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 176(1 Pt 1): 189–195

    PubMed  CAS  Article  Google Scholar 

  97. 97.

    Lesniak-Sobelga A, Tracz W, Kostkiewicz M, Podolec P and Pasowicz M (2004). Clinical and echocardiographic assessment of pregnant women with valvular heart diseases – maternal and fetal outcome. Int J Cardiol 94: 15–23

    PubMed  Article  Google Scholar 

  98. 98.

    Lewis G, Drife J and Botting B et al (1998). Why mothers die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994–1996. Her Majesty’s Stationary Office, London

    Google Scholar 

  99. 99.

    Magee LA, Duley L (2003) Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev CD002863

  100. 100.

    Magee LA, Schick B and Donnenfeld AE et al (1996). The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 174: 823–828

    PubMed  CAS  Article  Google Scholar 

  101. 101.

    Magee LA, Ornstein MP and von Dadelszen P (1999). Fortnightly review: management of hypertension in pregnancy. BMJ 318(7194): 1332–1336

    PubMed  CAS  Google Scholar 

  102. 102.

    Magee LA, Cham C, Waterman EJ, Ohlsson A and von Dadelszen P (2003). Hydralazine for treatment of severe hypertension in pregnancy: metaanalysis. BMJ 327(7421): 955–960

    PubMed  CAS  Article  Google Scholar 

  103. 103.

    Maisch B, Lamparter S, Ristić A and Pankuweit S (2003). Pregnancy and cardiomyopathies. Herz 28: 196–208

    PubMed  Article  Google Scholar 

  104. 104.

    Martínez-Reding J, Cordero A, Kuri J, Martínez-Ríos MA and Salazar E (1998). Treatment of severe mitral stenosis with percutaneous balloon valvotomy in pregnant patients. Clin Cardiol 21: 659–663

    PubMed  Google Scholar 

  105. 105.

    McFaul PB, Dornan JC, Lamki H and Boyle D (1988). Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 95: 861–867

    PubMed  CAS  Google Scholar 

  106. 106.

    McKenna R, Cole ER and Vasan U (1983). Is warfarin sodium contraindicated in the lactating mother?. J Pediatr 103: 325–327

    PubMed  CAS  Article  Google Scholar 

  107. 107.

    Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH and Mulder BJ (2005). Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 26: 914–920

    PubMed  Article  Google Scholar 

  108. 108.

    Meili G, Huch R, Huch A and Zimmermann R (2003). Maternal mortality in Switzerland 1985–1994. Gynäkol Geburtshilfliche Rundsch 43: 158–165

    PubMed  Article  Google Scholar 

  109. 109.

    Moll W (2001). Physiological cardiovascular adaptation in pregnancy – its significance for cardiac diseases. Z Kardiol 90(Suppl 4): 2–9

    PubMed  Google Scholar 

  110. 110.

    Montoya ME, Karnath BM and Ahmad M (2003). Endocarditis during pregnancy. South Med J 96: 1156–1157

    PubMed  Article  Google Scholar 

  111. 111.

    Naber CK, Bauhofer A and Block M et al (2004). S2-Leitlinie zur Diagnostik und Therapie der infektiösen Endokarditis. Z Kardiol 93: 1005–1021

    PubMed  CAS  Article  Google Scholar 

  112. 112.

    Naber CK, Al-Nawas B and Baumgartner H et al (2007). Prophylaxe der infektiösen Endokarditis. DGK Positionspapier. Kardiologe 1: 243–250

    Article  Google Scholar 

  113. 113.

    Natale A, Davidson T, Geiger MJ and Newby K (1997). Implantable cardioverter-defibrillators and pregnancy: a safe combination. Circulation 96: 2808–2812

    PubMed  CAS  Google Scholar 

  114. 114.

    National High Blood Pressure Education Program Working Group (2000) Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183: 1–22

    Google Scholar 

  115. 115.

    Neumayer U and Somerville J (1997). Outcome of pregnancies in patients with complex pulmonary atresia. Heart 78: 16–21

    PubMed  CAS  Google Scholar 

  116. 116.

    Nienaber CA and Von Kodolitsch Y (1999). Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Car-diol Rev 7: 332–341

    CAS  Article  Google Scholar 

  117. 117.

    Oakley CM (1995). Anticoagulants in pregnancy. Br Heart J 74: 107–111

    PubMed  CAS  Article  Google Scholar 

  118. 118.

    Oakley CM (1997). Pregnancy and congenital heart disease. Heart 78: 12–14

    PubMed  CAS  Google Scholar 

  119. 119.

    Oakley C, Child A and Jung B et al (2003). Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 24: 761–781

    Article  Google Scholar 

  120. 120.

    O’Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I and Turpie AG (2007). Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med 146: 184–187

    PubMed  Google Scholar 

  121. 121.

    Oran B, Lee-Parritz A and Ansell J (2004). Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost 92: 747–751

    PubMed  CAS  Google Scholar 

  122. 122.

    Page RL (1995). Treatment of arrhythmias during pregnancy. Am Heart J 130: 871–876

    PubMed  CAS  Article  Google Scholar 

  123. 123.

    Pearson GD, Veille JC and Rahimtoola S et al (2000). Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283: 1183–1188

    PubMed  CAS  Article  Google Scholar 

  124. 124.

    Perloff JK and Child JS (1998). Congenital heart disease in adults, 2nd edn. WB Saunders, Philadelphia

    Google Scholar 

  125. 125.

    Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D and Rabajoli F (1994). Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 89: 2673–2676

    PubMed  CAS  Google Scholar 

  126. 126.

    Presbitero P, Prever SB and Aruta E (1995). The Eisenmenger syndrome. Is it still a problem for the cardiologist in adults?. G Ital Cardiol 25: 89–94

    PubMed  CAS  Google Scholar 

  127. 127.

    Presbitero P, Prever SB and Brusca A (1996). Interventional cardiology in pregnancy. Eur Heart J 17: 182–188

    PubMed  CAS  Google Scholar 

  128. 128.

    Qasqas SA, McPherson C, Frishman WH and Elkayam U (2004). Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev 12: 240–261

    PubMed  Article  Google Scholar 

  129. 129.

    Rallings P, Exner T and Abraham R (1989). Coronary artery vasculitis and myocardial infarction associated with antiphospholipid antibodies in a pregnant woman. Aust N Z J Med 19: 347–350

    PubMed  CAS  Google Scholar 

  130. 130.

    Rashba EJ, Zareba W and Moss AJ et al (1998). Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation 97: 451–456

    PubMed  CAS  Google Scholar 

  131. 131.

    Rath W (2005) Hypertensive Schwangerschaftserkrankungen. In: Rath W, Friese K (Hrsg) Erkrankungen in der Schwangerschaft. Thieme, Stuttgart New York

  132. 132.

    Rath W, Heilmann L, Faridi A and Klockenbusch W (2002). Empfehlungen zur Diagnostik und Therapie des Bluthochdrucks in der Schwangerschaft. Frauenarzt 43: 847–851

    Google Scholar 

  133. 133.

    Rathore SS, Wang Y and Krumholz HM (2002). Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347: 1403–1411

    PubMed  CAS  Article  Google Scholar 

  134. 134.

    Rathore SS, Curtis JP, Wang Y, Bristow MR and Krumholz HM (2003). Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289: 871–878

    PubMed  CAS  Article  Google Scholar 

  135. 135.

    Redman CW (1991). Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 17: 149–153

    PubMed  CAS  Google Scholar 

  136. 136.

    Reynolds B, Butters L, Evans J, Adams T and Rubin PC (1984). First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 59: 1061–1063

    PubMed  CAS  Article  Google Scholar 

  137. 137.

    Rogge C, Geibel A, Bode C and Zehender M (2004). Cardiac arrhythmias and sudden cardiac death in women. Z Kardiol 93: 427–438

    PubMed  CAS  Article  Google Scholar 

  138. 138.

    Rokey R and Belfort M (2002). Peripartum cardiomyopathy. In: Wilansky, S and Willerson, JT (eds) Heart disease in women. Churchill Livingstone, New York, pp 487–495

    Google Scholar 

  139. 139.

    Rossiter JP, Repke JT, Morales AJ, Murphy EA and Pyeritz RE (1995). A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 173: 1599–1606

    PubMed  CAS  Article  Google Scholar 

  140. 140.

    Sanson BJ, Lensing AW and Prins MH et al (1999). Safety of low-molecularweight heparin in pregnancy: a systematic review. Thromb Haemost 81: 668–672

    PubMed  CAS  Google Scholar 

  141. 141.

    Sareli P, England MJ and Berk MR et al (1989). Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol 63: 1462–1465

    PubMed  CAS  Article  Google Scholar 

  142. 142.

    Sbarouni E and Oakley CM (1994). Outcome of pregnancy in women with valve prostheses. Br Heart J 71: 196–201

    PubMed  CAS  Article  Google Scholar 

  143. 143.

    Schaefer C (2003). Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. Birth Defects Res A Clin Mol Teratol 67: 591–594

    PubMed  CAS  Article  Google Scholar 

  144. 144.

    Schaefer C, Hannemann D and Meister R et al (2006). Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 95: 949–957

    PubMed  CAS  Google Scholar 

  145. 145.

    Schaefer C, Spielmann H, Vetter K (2006) Arzneiverordnung in der Schwangerschaft und Stillzeit, 7. Aufl. Urban & Fischer, München

  146. 146.

    Shivvers SA, Keffer JH, Ramin SM and Wians FH (1999). Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol 180(1 Pt 1): 122

    PubMed  CAS  Article  Google Scholar 

  147. 147.

    Shotan A, Widerhorn J, Hurst A and Elkayam U (1994). Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96: 451–456

    PubMed  CAS  Article  Google Scholar 

  148. 148.

    Sibai BM (1996). Treatment of hypertension in pregnant women. N Engl J Med 335: 257–265

    PubMed  CAS  Article  Google Scholar 

  149. 149.

    Sibai BM (2002). Chronic hypertension in pregnancy. Obstet Gynecol 100: 369–377

    PubMed  Article  Google Scholar 

  150. 150.

    Sibai BM, Barton JR, Akl S, Sarinoglu C and Mercer BM (1992). A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term. Am J Obstet Gynecol 167(4 Pt 1): 879–884

    PubMed  CAS  Google Scholar 

  151. 151.

    Silversides CK, Colman JM, Sermer M and Siu SC (2003). Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 91: 1382–1385

    PubMed  Article  Google Scholar 

  152. 152.

    Siu SC, Sermer M and Harrison DA et al (1997). Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 96: 2789–2794

    PubMed  CAS  Google Scholar 

  153. 153.

    Siu S, Chitayat D and Webb G (1999). Pregnancy in women with congenital heart defects: what are the risks?. Heart 81: 225–226

    PubMed  CAS  Google Scholar 

  154. 154.

    Siu SC, Sermer M and Colman JM et al (2001). Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 104: 515–521

    PubMed  CAS  Article  Google Scholar 

  155. 155.

    Siu SC, Colman JM and Sorensen S et al (2002). Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 105: 2179–2184

    PubMed  Article  Google Scholar 

  156. 156.

    Sivadasanpillai H, Srinivasan A, Sivasubramoniam S, Mahadevan KK, Kumar A, Titus T and Tharakan J (2005). Long-term outcome of patients undergoing balloon mitral valvotomy in pregnancy. Am J Cardiol 95: 1504–1506

    PubMed  Article  Google Scholar 

  157. 157.

    Souza DS, Bomfim V, Skoglund H, Dashwood MR, Borowiec JW, Bodin L and Filbey D (2001). High early patency of saphenous vein graft for coronary artery bypass harvested with surrounding tissue. Ann Thorac Surg 71: 797–800

    PubMed  CAS  Article  Google Scholar 

  158. 158.

    Steer PJ, Little MP, Kold-Jensen T, Chapple J and Elliott P (2004). Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ 329(7478): 1312

    PubMed  Article  Google Scholar 

  159. 159.

    Subtil D, Goeusse P and Puech F et al (2003). Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Régional Aspirine Mère-Enfant study (Part 1). BJOG 110: 475–484

    PubMed  CAS  Google Scholar 

  160. 160.

    Tan HL and Lie KI (2001). Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22: 458–464

    PubMed  CAS  Article  Google Scholar 

  161. 161.

    Thaman R, Varnava A and Hamid MS et al (2003). Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart 89: 752–756

    PubMed  CAS  Article  Google Scholar 

  162. 162.

    Therrien J, Barnes I and Somerville J (1999). Outcome of pregnancy in patients with congenitally corrected transposition of the great arteries. Am J Cardiol 84: 820–824

    PubMed  CAS  Article  Google Scholar 

  163. 163.

    Thorne SA (2004). Pregnancy in heart disease. Heart 90: 450–456

    PubMed  CAS  Article  Google Scholar 

  164. 164.

    Tidswell M (2004). Peripartum cardiomyopathy. Crit Care Clin 20: 777–788, xi

    PubMed  Article  Google Scholar 

  165. 165.

    Trappe HJ and Pfitzner P (2001). Cardiac arrhythmias in pregnancy. Z Kardiol 90(Suppl 4): 36–44

    PubMed  Google Scholar 

  166. 166.

    Vahanian A, Baumgartner H and Bax J et al (2007). Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28: 230–268

    PubMed  Google Scholar 

  167. 167.

    Verstraete M, Prentice CR, Samama M and Verhaeghe R (2000). A European view on the North American fifth consensus on antithrombotic therapy. Chest 117: 1755–1770

    PubMed  CAS  Article  Google Scholar 

  168. 168.

    Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N and Cotrufo M (1999). Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 33: 1637–1641

    PubMed  CAS  Article  Google Scholar 

  169. 169.

    von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G and Magee LA (2000). Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355(9198): 87–92

    Article  Google Scholar 

  170. 170.

    Weiss BM and Hess OM (2000). Pulmonary vascular disease and pregnancy: current controversies, management strategies and perspectives. Eur Heart J 21: 104–115

    PubMed  CAS  Article  Google Scholar 

  171. 171.

    Weiss BM, von Segesser LK, Alon E, Seifert B and Turina MI (1998). Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol 179(6 Pt 1): 1643–1653

    PubMed  CAS  Article  Google Scholar 

  172. 172.

    Weiss BM, Zemp L, Seifert B and Hess OM (1998). Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 31: 1650–1657

    PubMed  CAS  Article  Google Scholar 

  173. 173.

    Welsch H (1997). Müttersterblichkeit während Schwangerschaft und post abortum. Definitionen – Amtliche Landesstatistiken. Der Gynäkologe 30: 682–693

    Article  Google Scholar 

  174. 174.

    Whittemore R (1983). Congenital heart disease: its impact on pregnancy. Hosp Pract (Off Ed) 18: 65–74

    CAS  Google Scholar 

  175. 175.

    Whittemore R, Hobbins JC and Engle MA (1982). Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 50: 641–651

    PubMed  CAS  Article  Google Scholar 

  176. 176.

    Wilson AM, Boyle AJ and Fox P (2004). Management of ischaemic heart disease in women of child-bearing age. Intern Med J 34: 694–697

    PubMed  CAS  Article  Google Scholar 

  177. 177.

    Wilson NJ, Clarkson PM, Barratt-Boyes BG, Calder AL, Whitlock RM, Easthope RN and Neutze JM (1998). Long-term outcome after the mustard repair for simple transposition of the great arteries. 28-year follow-up. J Am Coll Cardiol 32: 758–765

    PubMed  CAS  Article  Google Scholar 

  178. 178.

    Wilson W, Taubert KA and Gewitz M et al (2007). Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116: 1736–1754

    PubMed  Article  Google Scholar 

  179. 179.

    Wolbrette D (2003). Treatment of arrhythmias during pregnancy. Curr Womens Health Rep 3: 135–139

    PubMed  Google Scholar 

  180. 180.

    Yentis SM, Steer PJ and Plaat F (1998). Eisenmenger’s syndrome in pregnancy: maternal and fetal mortality in the 1990s. Br J Obstet Gynaecol 105: 921–922

    PubMed  CAS  Google Scholar 

  181. 181.

    Yentis S, Gatzoulis MA and Steer P (2003). Pregnancy and coarctation of the aorta. J R Soc Med 96: 471

    PubMed  Article  Google Scholar 

  182. 182.

    Zehender M, Meinertz T, Faber T, Caspary A, Jeron A, Bremm K and Just H (1997). Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators. J Am Coll Cardiol 29: 1028–1034

    PubMed  CAS  Article  Google Scholar 

  183. 183.

    Zuber M, Gautschi N, Oechslin E, Widmer V, Kiowski W and Jenni R (1999). Outcome of pregnancy in women with congenital shunt lesions. Heart 81: 271–275

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Vera Regitz-Zagrosek.

Additional information

Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie M. Borggrefe, M. Böhm, J. Brachmann, H.-R. Figulla, G. Hasenfuß, H.M. Hoffmeister, A. Osterspey, K. Rybak, U. Sechtem, S. Silber

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Regitz-Zagrosek, V., Gohlke-Bärwolf, C., Geibel-Zehender, A. et al. Herzerkrankungen in der Schwangerschaft. Clin Res Cardiol 97, 630–665 (2008). https://doi.org/10.1007/s00392-008-0685-2

Download citation